Curbing antimicrobial resistance in post-COVID Africa: Challenges, actions and recommendations.
Africa
COVID‐19
antimicrobial resistance
anti‐infective agents
drug resistance
infection control
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
06
02
2022
revised:
04
07
2022
accepted:
05
07
2022
entrez:
11
8
2022
pubmed:
12
8
2022
medline:
12
8
2022
Statut:
epublish
Résumé
Antimicrobial self-medication and use have significantly increased in the COVID-19 era-increasing antibiotic consumption and resulting in a high prevalence of antimicrobial resistance in Africa (AMR). We conducted a narrative review to investigate challenges associated with curbing AMR in a post-COVID-19 setting in Africa, suggesting practical measures applicable for policy-informed implementation. A narrative review was performed to pinpoint AMR challenges and actions on the African continent. A comprehensive search was conducted in the scientific databases that include PubMed, PubMed Central and Google Scholar using predetermined search terms. The emergence of the COVID-19 outbreak has added to the challenges of tackling AMR on the continent, which has jeopardized AMR interventions' hard-won gains. Identified challenges have been Health systems disruption, Irrational Antimicrobial Use, Weak Antimicrobials Regulatory Ecosystem, Inefficient Population Infection Prevention, and Control Practices, Inadequate access to Health Services and data challenge on AMR surveillance. The COVID-19 pandemic fueled AMR in Africa. There is a need for AMR control post-COVID, such as measures for ongoing antimicrobial stewardship and good infection control practices. Further, curbing AMR requires rigorous regulatory enforcement and efficient AMR Surveillance. There should be a body to raise AMR awareness among the population. Research, Innovation and Technology could play an essential role supported by capacity building and global partnership.
Sections du résumé
Background
UNASSIGNED
Antimicrobial self-medication and use have significantly increased in the COVID-19 era-increasing antibiotic consumption and resulting in a high prevalence of antimicrobial resistance in Africa (AMR). We conducted a narrative review to investigate challenges associated with curbing AMR in a post-COVID-19 setting in Africa, suggesting practical measures applicable for policy-informed implementation.
Method
UNASSIGNED
A narrative review was performed to pinpoint AMR challenges and actions on the African continent. A comprehensive search was conducted in the scientific databases that include PubMed, PubMed Central and Google Scholar using predetermined search terms.
Results
UNASSIGNED
The emergence of the COVID-19 outbreak has added to the challenges of tackling AMR on the continent, which has jeopardized AMR interventions' hard-won gains. Identified challenges have been Health systems disruption, Irrational Antimicrobial Use, Weak Antimicrobials Regulatory Ecosystem, Inefficient Population Infection Prevention, and Control Practices, Inadequate access to Health Services and data challenge on AMR surveillance.
Conclusion
UNASSIGNED
The COVID-19 pandemic fueled AMR in Africa. There is a need for AMR control post-COVID, such as measures for ongoing antimicrobial stewardship and good infection control practices. Further, curbing AMR requires rigorous regulatory enforcement and efficient AMR Surveillance. There should be a body to raise AMR awareness among the population. Research, Innovation and Technology could play an essential role supported by capacity building and global partnership.
Identifiants
pubmed: 35949681
doi: 10.1002/hsr2.771
pii: HSR2771
pmc: PMC9358668
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e771Informations de copyright
© 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
BMJ Glob Health. 2021 Dec;6(12):
pubmed: 34853031
Front Public Health. 2021 Jun 04;9:606801
pubmed: 34150693
Int J Hyg Environ Health. 2018 Apr;221(3):409-422
pubmed: 29352706
BMJ Open. 2021 Mar 8;11(3):e041418
pubmed: 34006022
Lancet. 2021 Mar 20;397(10279):1063-1074
pubmed: 33676597
One Health. 2020 Sep 29;11:100171
pubmed: 33392372
Antibiotics (Basel). 2021 Aug 13;10(8):
pubmed: 34439026
Elife. 2021 Feb 16;10:
pubmed: 33588991
Glob Health Action. 2021 Jan 1;14(1):1868055
pubmed: 33475046
Antimicrob Resist Infect Control. 2022 Jan 24;11(1):15
pubmed: 35073967
Afr J Lab Med. 2019 Dec 06;8(1):1109
pubmed: 31850160
Antimicrob Resist Infect Control. 2022 Feb 14;11(1):34
pubmed: 35164886
Antibiotics (Basel). 2021 Mar 09;10(3):
pubmed: 33803077
Antibiotics (Basel). 2021 Oct 29;10(11):
pubmed: 34827257
J Antimicrob Chemother. 2021 Oct 11;76(11):3045-3058
pubmed: 34473285
Future Sci OA. 2021 Jun 10;7(8):FSO736
pubmed: 34290883
Afr J Lab Med. 2018 Dec 06;7(2):924
pubmed: 30568909
Lancet Reg Health West Pac. 2021 Jan 23;7:100084
pubmed: 34327414
Malar J. 2007 Jun 29;6:83
pubmed: 17603898
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
PLoS One. 2021 May 7;16(5):e0251301
pubmed: 33961678
BMJ Glob Health. 2022 Mar;7(3):
pubmed: 35232813
BMC Infect Dis. 2017 Sep 11;17(1):616
pubmed: 28893183
J Antimicrob Chemother. 2020 Dec 1;75(12):3413-3416
pubmed: 32830266
J Glob Antimicrob Resist. 2021 Jun;25:5-7
pubmed: 33662647
Infect Dis (Auckl). 2021 Jul 31;14:11786337211033870
pubmed: 34376994
Antibiotics (Basel). 2022 Feb 13;11(2):
pubmed: 35203846
PLoS One. 2019 Oct 9;14(10):e0222922
pubmed: 31596861
N Engl J Med. 2014 Mar 6;370(10):950-7
pubmed: 24597868
Int J Infect Dis. 2022 Apr;117:174-178
pubmed: 35150912
Health Res Policy Syst. 2011 Jun 09;9:22
pubmed: 21658259
Trans R Soc Trop Med Hyg. 2021 Oct 1;115(10):1122-1129
pubmed: 33772597
Lancet Infect Dis. 2019 Nov;19(11):e371-e384
pubmed: 31588040
Trop Med Int Health. 2021 Oct;26(10):1153-1163
pubmed: 34139031
Pathog Glob Health. 2015;109(7):309-18
pubmed: 26343252
Health Promot Perspect. 2021 Aug 18;11(3):263-266
pubmed: 34660219
Glob Health Action. 2019;12(1):1638144
pubmed: 31294677
Trop Med Health. 2021 Jun 23;49(1):51
pubmed: 34162445
Antimicrob Resist Infect Control. 2017 May 15;6:47
pubmed: 28515903
BMJ Open. 2021 May 11;11(5):e048720
pubmed: 33980534
Antimicrob Resist Infect Control. 2021 Jan 14;10(1):13
pubmed: 33446266